22nd Century Announces $40 Million Common Stock Registered Direct Offering
Biotechnology June 7, 2021
Ryan Allway June 7th, 2021 Financing Provides Support to the Company’s Strategic Objectives Across All Its Plant Franchises. BUFFALO, N.Y., June 07, 2021 (GLOBE NEWSWIRE) — 22nd Century Group, Inc. (NYSE American: XXII), a leading plant-based biotechnology company focused on tobacco harm reduction, reduced nicotine tobacco, and hemp/cannabis research, today... Read more
